Most Recent

image: Ebola Mutation Rate Quibble

Ebola Mutation Rate Quibble

By | March 27, 2015

A study suggests that the virus may not be evolving as quickly as a previous group estimated.

0 Comments

image: Genome Nation

Genome Nation

By | March 27, 2015

Researchers perform whole-genome sequencing on roughly 1 percent of the Icelandic population.

0 Comments

image: Short, Strong Signals

Short, Strong Signals

By | March 25, 2015

Methylation increases both the activity and instability of the signaling protein Notch.

0 Comments

image: Irisin Skepticism Goes Way Back

Irisin Skepticism Goes Way Back

By | March 18, 2015

Post-publication peer reviewers had questioned data about the supposed fat-browning enzyme from the get-go.

1 Comment

image: “Yeti” Just a Himalayan Bear?

“Yeti” Just a Himalayan Bear?

By | March 17, 2015

Latest analysis suggests the yeti is a known bear species, not the new, hybrid species suggested by a previous study.

0 Comments

image: 23andMe Enters Drug Development

23andMe Enters Drug Development

By | March 12, 2015

The personal genomics firm announces plans to make medicines.

4 Comments

image: Horizontal Gene Transfer a Hallmark of Animal Genomes?

Horizontal Gene Transfer a Hallmark of Animal Genomes?

By | March 12, 2015

Foreign genes in animal genomes may be of bacterial or fungal origin, according to a new analysis.

4 Comments

image: Oldest <em>Homo</em> Remains Yet Found

Oldest Homo Remains Yet Found

By | March 4, 2015

A newly discovered 2.8 million-year-old jawbone is thought to be that of a direct human ancestor.

0 Comments

image: Genome Digest

Genome Digest

By | March 4, 2015

What researchers are learning as they sequence, map, and decode species’ genomes

0 Comments

image: A Deathly Pallor

A Deathly Pallor

By | March 1, 2015

Global warming could lead to lighter-colored insects with waning immune defenses.

0 Comments

Popular Now

  1. UC Berkeley Receives CRISPR Patent in Europe
    Daily News UC Berkeley Receives CRISPR Patent in Europe

    The European Patent Office will grant patent rights over the use of CRISPR in all cell types to a University of California team, contrasting with a recent decision in the U.S.

  2. DNA Replication Errors Contribute to Cancer Risk
  3. Should Healthy People Have Their Exomes Sequenced?
    Daily News Should Healthy People Have Their Exomes Sequenced?

    With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.  

  4. Rethinking a Cancer Drug Target
    Daily News Rethinking a Cancer Drug Target

    The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.

Business Birmingham